These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 11798260)
1. A method to detect the incidence of hepatitis C infection among injecting drug users in Glasgow 1993-98. Roy KM; Goldberg D; Taylor A; Hutchinson S; MacDonald L; Wilson KS; Cameron SO J Infect; 2001 Oct; 43(3):200-5. PubMed ID: 11798260 [TBL] [Abstract][Full Text] [Related]
2. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users. Micallef JM; Macdonald V; Jauncey M; Amin J; Rawlinson W; van Beek I; Kaldor JM; White PA; Dore GJ J Viral Hepat; 2007 Jun; 14(6):413-8. PubMed ID: 17501762 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus among genitourinary clinic attenders in Scotland: unlinked anonymous testing. Goldberg D; Cameron S; Sharp G; Burns S; Scott G; Molyneaux P; Scoular A; Downie A; Taylor A Int J STD AIDS; 2001 Jan; 12(1):17-21. PubMed ID: 11177477 [TBL] [Abstract][Full Text] [Related]
4. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050 [TBL] [Abstract][Full Text] [Related]
5. Failure to diagnose recent hepatitis C virus infections in London injecting drug users. Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis. Judd A; Hutchinson S; Wadd S; Hickman M; Taylor A; Jones S; Parry JV; Cameron S; Rhodes T; Ahmed S; Bird S; Fox R; Renton A; Stimson GV; Goldberg D J Viral Hepat; 2005 Nov; 12(6):655-62. PubMed ID: 16255768 [TBL] [Abstract][Full Text] [Related]
7. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users. Devi KhS; Brajachand N; Singh HL; Singh YM J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404 [TBL] [Abstract][Full Text] [Related]
8. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users. Roy E; Alary M; Morissette C; Leclerc P; Boudreau JF; Parent R; Rochefort J; Claessens C; Int J STD AIDS; 2007 Jan; 18(1):23-7. PubMed ID: 17326858 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia. Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience. Roy E; Boudreau JF; Boivin JF Drug Alcohol Depend; 2009 Jun; 102(1-3):158-61. PubMed ID: 19251382 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users. Roy KM; Goldberg DJ; Hutchinson S; Cameron SO; Wilson K; MacDonald L J Med Virol; 2004 Sep; 74(1):62-6. PubMed ID: 15258969 [TBL] [Abstract][Full Text] [Related]
12. Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland. Hutchinson SJ; Bird SM; Goldberg DJ Hepatology; 2005 Sep; 42(3):711-23. PubMed ID: 16116637 [TBL] [Abstract][Full Text] [Related]
13. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C infection among drug users in northern Thailand. Jittiwutikarn J; Thongsawat S; Suriyanon V; Maneekarn N; Celentano D; Razak MH; Srirak N; Vongchak T; Kawichai S; Thomas D; Sripaipan T; Netski D; Ananthakrishnan A; Nelson KE Am J Trop Med Hyg; 2006 Jun; 74(6):1111-6. PubMed ID: 16760529 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus reinfection in injection drug users. Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW Hepatology; 2006 Nov; 44(5):1139-45. PubMed ID: 17058216 [TBL] [Abstract][Full Text] [Related]
16. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan. Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London. Mohsen AH; Murad S; Easterbrook PJ HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288 [TBL] [Abstract][Full Text] [Related]
18. Cumulative incidence of hepatitis C seroconversion in a cohort of seronegative injecting drug users. Brunton C; Kemp R; Raynel P; Harte D; Baker M N Z Med J; 2000 Mar; 113(1106):98-101. PubMed ID: 10836310 [TBL] [Abstract][Full Text] [Related]
19. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia. Maher L; Chant K; Jalaludin B; Sargent P J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287 [TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan. Satoh Y; Hino K; Kato T; Mizokami M; Yamashita S; Nakamura H; Okita K J Gastroenterol Hepatol; 2004 Nov; 19(11):1305-11. PubMed ID: 15482539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]